Each fall, the ACR/ARHP Annual Meeting takes place in a major U.S. city. More than 15,000 people fill the cavernous halls of the area convention center and nearby hotels to attend scientific and educational sessions, scan the latest data on posters and mingle with colleagues at the annual Presidents’ Reception. What most attendees may not…
SAN FRANCISCO—Two hundred years ago, physicians knew nothing about what caused various forms of arthritis. Today, we have more clues about what may trigger rheumatic diseases, but still can’t pinpoint the culprits that set scores of inflammatory conditions in motion. Researchers discussed some of the background and recent findings that point to what immunologists call…
“Treat to target regardless of disease activity level” tops the list of recommendations for both early and established RA in the 2015 Guideline for the Treatment of Rheumatoid Arthritis. The guideline addresses six major topics, including DMARDs, glucocorticoids and biologics, and includes 74 recommendations. These recommendations are not prescriptive, and the treatment decisions should be made by physicians and patients together…